SCHEMBL13947075

SCHEMBL13947075

Cc1ccc(C(=O)NCc2c(C)cc(C)nc2Cl)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 2/20 0.47
▸ POLB P06746 3/20 0.47
▸ RXFP1 Q9HBX9 1/20 0.47
▸ MAPT P10636 3/20 0.46
▸ HPGD P15428 2/20 0.46
▸ TDP1 Q9NUW8 3/20 0.44
▸ ALDH1A1 P00352 3/20 0.44
▸ HTT P42858 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ SMN1; SMN2 Q16637 4/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ LMNA P02545 1/20 0.43
▸ MAPK14 Q16539 2/20 0.43
▸ MMP2 P08253 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ STAT3 P40763 1/20 0.43
▸ MMP13 P45452 1/20 0.43
▸ KLKB1 P03952 1/20 0.42
▸ MAP4K1 Q92918 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13947209 0.78 MAPT (0.52) TP53POLBRXFP1MAPTHPGD
SCHEMBL14972144 0.74 SMN1; SMN2 (0.42) TP53POLBMAPTHPGDALDH1A1
SCHEMBL13947260 0.73 POLB (0.57) POLBMAPTHPGDTDP1ALDH1A1
SCHEMBL14966778 0.73 NPC1 (0.49) TP53POLBMAPTALDH1A1HTT
SCHEMBL14966192 0.73 EPHX2 (0.43) POLBRXFP1MAPTSMN1; SMN2MEN1
SCHEMBL14966808 0.71 KLKB1 (0.51) MAPTHPGDALDH1A1KDM4ESMN1; SMN2
SCHEMBL14966526 0.71 KLKB1 (0.40) POLBRXFP1HPGDALDH1A1SMN1; SMN2
SCHEMBL14966781 0.71 RAB9A (0.47) POLBMAPTHPGDALDH1A1KDM4E
SCHEMBL14966830 0.70 KLKB1 (0.44) ALDH1A1KDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL14967422 0.70 MAPK14 (0.56) HPGDALDH1A1HTTSMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090029990-A1 Dihydropteridinones in the treatment of respiratory diseases MAIER UDO 2009-01-29 — — US disclosed
US-20070043055-A1 Dihydropteridinones in the treatment of respiratory diseases BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-02-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043055-A1 Dihydropteridinones in the treatment of respiratory diseases QDPR, DHPS, NDUFS6 TP53 3400/4885POLB 3804/4885RXFP1 83/4885
US-20090029990-A1 Dihydropteridinones in the treatment of respiratory diseases QDPR, DHPS, NDUFS6 TP53 3400/4885POLB 3804/4885RXFP1 83/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback